For Current Gilead Employees and Contractors:

Please log onto your Internal Career Site to apply for this job.

At Gilead we believe every employee deserves a great leader. As a people leader now or in the future, we expect that you will model and create an environment of inclusion, be intentionally focused on the hiring, development, growth and retention of talent, and empower teams to align and achieve goals.

Job Description

Senior Research Scientist In Vivo Pharmacology

Gilead Sciences (foster city, CA) is looking for accomplished scientist/group leader to join the group and pursue cutting-edge discovery and translational research in immunology, autoimmune diseases, and chronic fibrotic diseases. The candidate will lead a group of scientists in Gilead Seattle site and collaborate with other functional areas to implemental preclinical animal models to test/optimize therapeutics in various inflammation disease area including inflammatory bowel disease, rheumatoid arthritis, systemic lupus erythematosus, Idiopathic pulmonary fibrosis, and non-alcoholic steatohepatitis. The position will require both good communication and managerial skills to interface effectively with other functional groups (discovery biology, medicinal chemistry, protein and antibody engineering, histopathology, and bioinformatics) and manage activities of highly skilled scientists. The successful candidate will also participate in evaluation of external licensing opportunities. In addition, we anticipate the candidate to participate in the inflammation disease area strategic planning and provide scientific inputs on novel emerging therapeutics in chronic inflammation disease and therapeutic combination options.  If you are interested in pioneering scientific discovery, innovation, and drug development, join us to achieve your dreams.  We are promoting an innovative, collaborative, and grassroots based scientific environment.

Gilead Sciences is a world leader in antiviral research having developed small molecule compounds that have revolutionized the treatment of HIV, HCV, and HBV. Over the last 5 years, Gilead has significantly broadened its scope to encompass unmet medical needs in inflammatory and chronic fibrotic diseases.

Qualifications and requirements:

·Applicants must have a PhD or equivalent degree and at least 8 years of relevant post-graduate independent research or drug development experience in immunology, molecular biology, or autoimmune diseases.

·A strong technical background in molecular biology, biochemistry, immunology, or in vivo autoimmune disease models is desired.

·The candidate must demonstrate critical analytical skill and ability to lead independent hypothesis-driven biological research, as exemplified by high quality publications or drug developmental achievements.  

·Candidates must have prior experience in in vivo pharmacology of testing/optimizing therapeutic candidates in preclinical disease models, and management of transgenic animal colonies.

·Strong communication skills required, with an ability to communicate and scientifically engage individuals across a large breadth of levels and translate ideas and data into concise written and verbal communications.

·Please note worksite is South San Francisco, CA

For jobs in the United States:

As an equal opportunity employer, Gilead Sciences Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans’ Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact [email protected] for assistance.

Following extensive monitoring, research, consideration of business implications and advice from internal and external experts, Gilead has made the decision to require all U.S., Canada, Australia, Singapore, and Hong Kong employees and contractors to receive the COVID-19 vaccines as a condition of employment. “Full vaccination” is defined as two weeks after both doses of a two-dose vaccine or two weeks since a single-dose vaccine has been administered. Anyone unable to be vaccinated, either because of a sincerely held religious belief or a medical condition or disability that prevents them from being vaccinated, can request a reasonable accommodation.​

For more information about equal employment opportunity protections, please view the ’Know Your Rights’ poster.

NOTICE: EMPLOYEE POLYGRAPH PROTECTION ACT
YOUR RIGHTS UNDER THE FAMILY AND MEDICAL LEAVE ACT

PAY TRANSPARENCY NONDISCRIMINATION PROVISION

Our environment respects individual differences and recognizes each employee as an integral member of our company. Our workforce reflects these values and celebrates the individuals who make up our growing team.

Gilead provides a work environment free of harassment and prohibited conduct. We promote and support individual differences and diversity of thoughts and opinion.

For Current Gilead Employees and Contractors:

Please log onto your Internal Career Site to apply for this job.